Reyes Financial Architecture »

Calidi Biotherapeutics shares owned by Reyes Financial Architecture

Quarter-by-quarter ownership of Calidi Biotherapeutics shares owned by Reyes Financial Architecture from 13F filings

Historical chart of Reyes Financial Architecture investment in Calidi Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Calidi Biotherapeutics held by Reyes Financial Architecture consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Calidi Biotherapeutics by Reyes Financial Architecture

Quarter filed Position value Share count Share price at filing
2025-09-30 $152 100 1.52

More positions owned by Reyes Financial Architecture

Wisdomtree Tr Floatng Rat Trea (USFR)
Spdr Gold Tr Gold Shs (GLD)
Thor Finl Technologies Tr Index Rotation (THIR)
Tidal Trust Iii Mrp Synthequity (SNTH)
Spdr Series Trust Bloomberg 1-3 Mo (BIL)
Vaneck Etf Trust Semiconductr Etf (SMH)
Listed Fds Tr Roundhill Magnif (MAGS)
Ishares Silver Tr Ishares (SLV)
World Gold Tr Spdr Gld Minis (GLDM)
Ark Etf Tr Innovation Etf (ARKK)
Vaneck Etf Trust Rare Earth And S (REMX)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for Reyes Financial Architecture

Top funds holding Calidi Biotherapeutics

HighTower Advisors
Vanguard Group
Geode Capital Management
Belpointe Asset Management
Warberg Asset Management
Rs Crum
UBS Group
Highbridge Capital Management
Finepoint Capital
Apollo Management Holdings
Royal Bank of Canada
Barrett & Company
Advisor Group Holdings
FMR
Tradewinds Capital Management

View all funds holding Calidi Biotherapeutics